Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial

David Laharie,Geert D'Haens,Maria Nachury,Guy Lambrecht,Peter Bossuyt,Yoram Bouhnik,Edouard Louis,Christien Janneke van der Woude,Anthony Buisson,Philippe Van Hootegem,Matthieu Allez,Jérôme Filippi,Hedia Brixi,Cyrielle Gilletta,Laurence Picon,Filip Baert,Séverine Vermeire, Nicolas Duveau,Laurent Peyrin-Biroulet

Clinical Gastroenterology and Hepatology（2022）

引用 7|浏览11

暂无评分

摘要

Achieving a sustained clinical remission off steroids with complete endoscopic remission in this cohort of 95 patients with early CD was not associated with less disease progression. Prospective trials to define the therapeutic goals that change the natural history of CD and prevent complications are needed.

查看译文

关键词

Crohn’s Disease,Deep Remission,Infliximab,Endoscopic Remission

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要